Found 12 matching trials
OC000459 Bronchial Allergen Challenge
PHASE2OC0000459 reduces inflammation in the tissues in response to allergic stimu...
Location
King's College London School of Medicine
Effect of OC459 on the Response to Rhinovirus Challenge in Asthma
PHASE2The aim of this study is to assess the effectiveness of a CRTH2 receptor an...
Location
St Mary's Hospital
Effect of OC000459 on Eosinophilic Airway Inflammation in Severe Asthma
PHASE2The aim is to study the effect of OC000459 on eosinophilic airway inflammat...
Location
University of Oxford
Evaluation of Metabolic Profile of OC000459
PHASE1An open label study in 9 male and 9 female healthy subjects to determine th...
A Study Of The Effects Of OC000459 In Subjects Known To Suffer From Grass Pollen Induced Allergic Rhinitis
PHASE2The study will assess the efficacy of OC000459 200 mg twice daily orally in...
Location
Vienna Challenge Chamber
OC000459 Dose Finding Study in Hay Fever Sufferers.
PHASE2The primary objective of this study is to evaluate a range of dose levels f...
Location
Allergie Zentrum Wien West, Vienna Challenge Chamber
The Effects of OC000459 on Nasal Mediators
PHASE1This is the first proof of concept study for OC000459 and is undertaken to ...
Location
National Heart & Lung Institute Clinical Studies Unit
Proof of Concept Study of OC000459 in Eosinophilic Esophagitis
PHASE2This will be a randomised, double blind, placebo controlled, parallel group...
Location
Swiss EoE Research Group
Effect of OC000459 on Moderate to Severe Atopic Dermatitis
PHASE2The purpose of this study is to determine whether OC000459 is in reducing d...
Location
University of Sheffield
Safety and Efficacy Study of OC000459 Dosed Twice Daily for 28 Days in Asthmatic Subjects
PHASE2The purpose of the study is to investigate the clinical effects of multiple...
Location
Research Institute of Pulmonology